crimeancongo hemorrhage fever ccf sever tickborn disease ended mani country africa middle east eastern europ asia report case fatal approve vaccine avail prelim protect vivo experiment demons previous present studi attend poxviru vector modify vaccine virus kara use develop recombin candid express glycoprotein cellular humor immunogen confirm two mouse strain include type interferon receptor knockout mouse suspect protect recipe anim lethal challenge model adapt metres infect via tick bite histopatholog viral load analysis expo even though exhibit clinic sign first demons efficacy 